Landscapes / Companies

Immunocore Ltd not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
IMC-R117C, Phase 1/2 trial completes
Drugs
5
in active trials · 9 in all
Trials
6 active
12 since 2021

Drugs5

DrugHow it worksPartnerStageNext dateDetails
Bispecific gp100 peptide-hla-directed CD3 T cell engager
Approved Mar 2028Phase 3 trial completes
—
Phase 3 16 Oct 2027Phase 3 trial completes
—
Phase 1/2 30 Nov 2026soonPhase 1/2 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes
—
Phase 1 Nov 2030Phase 1 trial completes

About

No active trial
HBV HCC Module, IMC-C103C, IMC-I109V, IMCnyeso
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Immunocore Ltd

Following is part of Solo: you see every change to Immunocore Ltd the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in